The focus of research in the Division of Hematology is to improve the diagnosis and treatment of hematologic diseases.

Physicians and scientists with special interests in certain diseases work together as a team, or disease-oriented group. Each member of the team lends a particular expertise. Some members provide basic research skills, and others provide clinical and clinical investigative skills.

See Division of Hematology Research

See Hematology clinical trials

Multiple myeloma is a cancer of the plasma cells. It's the second most common blood cancer in the United States after lymphoma, yet no new treatments have been developed in a generation. To better predict drug response, a team of Mayo Clinic hematologists are researching the reactions between various drugs and the genes that control cellular growth.

Read more in Discovery's Edge.